Zofran /00955301/


Indications and Reactions:

Role Indications Reactions
Secondary
Nausea 23.7%
Abdominal Pain Upper 15.8%
Crohn's Disease 15.8%
Irritable Bowel Syndrome 15.8%
Product Used For Unknown Indication 13.2%
Anxiety 5.3%
Panic Attack 5.3%
Osteomyelitis 2.6%
Pain 2.6%
Withdrawal Syndrome 50.0%
Insomnia 25.0%
Osteomyelitis 25.0%
Concomitant
Product Used For Unknown Indication 74.2%
Nausea 4.0%
Pain 3.1%
Hepatitis C 2.0%
Mantle Cell Lymphoma 1.8%
Vomiting 1.8%
Prophylaxis 1.7%
Plasma Cell Myeloma 1.5%
Hypertension 1.5%
Multiple Myeloma 1.0%
Acute Myeloid Leukaemia 0.9%
Anxiety 0.8%
Non-small Cell Lung Cancer 0.8%
Constipation 0.8%
Supplementation Therapy 0.8%
Depression 0.7%
Migraine 0.7%
Gastrooesophageal Reflux Disease 0.7%
Prostate Cancer 0.6%
Colorectal Cancer Metastatic 0.5%
Vomiting 23.3%
Weight Decreased 9.8%
Death 7.5%
Nausea 6.8%
Urinary Tract Infection 6.0%
Wrong Technique In Drug Usage Process 6.0%
Drug Ineffective 3.8%
Malignant Neoplasm Progression 3.8%
Pneumonia 3.8%
Respiratory Failure 3.8%
Off Label Use 3.0%
Pain 3.0%
Renal Failure 3.0%
Sepsis 3.0%
Fatigue 2.3%
Injection Site Pain 2.3%
Muscle Haemorrhage 2.3%
Pancreatitis 2.3%
Rib Fracture 2.3%
Tardive Dyskinesia 2.3%

Drug Data